NM_014855.3:c.329G>A

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_014855.3(AP5Z1):​c.329G>A​(p.Arg110Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000543 in 1,582,346 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R110W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000085 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000051 ( 1 hom. )

Consequence

AP5Z1
NM_014855.3 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.586

Publications

0 publications found
Variant links:
Genes affected
AP5Z1 (HGNC:22197): (adaptor related protein complex 5 subunit zeta 1) This gene was identified by genome-wide screen for genes involved in homologous recombination DNA double-strand break repair (HR-DSBR). The encoded protein was found in a complex with other proteins that have a role in HR-DSBR. Knockdown of this gene reduced homologous recombination, and mutations in this gene were found in patients with spastic paraplegia. It was concluded that this gene likely encodes a helicase (PMID:20613862). [provided by RefSeq, Jan 2011]
AP5Z1 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 48
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01993543).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AP5Z1NM_014855.3 linkc.329G>A p.Arg110Gln missense_variant Exon 3 of 17 ENST00000649063.2 NP_055670.1 O43299-1
AP5Z1NR_157345.1 linkn.422G>A non_coding_transcript_exon_variant Exon 3 of 17
AP5Z1NM_001364858.1 linkc.-103+405G>A intron_variant Intron 2 of 15 NP_001351787.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AP5Z1ENST00000649063.2 linkc.329G>A p.Arg110Gln missense_variant Exon 3 of 17 NM_014855.3 ENSP00000497815.1 O43299-1

Frequencies

GnomAD3 genomes
AF:
0.0000854
AC:
13
AN:
152218
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000709
AC:
17
AN:
239802
AF XY:
0.0000611
show subpopulations
Gnomad AFR exome
AF:
0.000201
Gnomad AMR exome
AF:
0.0000590
Gnomad ASJ exome
AF:
0.000318
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000562
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000510
AC:
73
AN:
1430010
Hom.:
1
Cov.:
31
AF XY:
0.0000525
AC XY:
37
AN XY:
704310
show subpopulations
African (AFR)
AF:
0.0000303
AC:
1
AN:
32958
American (AMR)
AF:
0.0000227
AC:
1
AN:
43962
Ashkenazi Jewish (ASJ)
AF:
0.000352
AC:
9
AN:
25598
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38780
South Asian (SAS)
AF:
0.0000470
AC:
4
AN:
85184
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51692
Middle Eastern (MID)
AF:
0.000881
AC:
5
AN:
5678
European-Non Finnish (NFE)
AF:
0.0000478
AC:
52
AN:
1087300
Other (OTH)
AF:
0.0000170
AC:
1
AN:
58858
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000853
AC:
13
AN:
152336
Hom.:
0
Cov.:
33
AF XY:
0.0000537
AC XY:
4
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000168
AC:
7
AN:
41578
American (AMR)
AF:
0.00
AC:
0
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68036
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000117
Hom.:
0
Bravo
AF:
0.0000945
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000353
AC:
3
ExAC
AF:
0.0000826
AC:
10
EpiCase
AF:
0.0000547
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 48 Uncertain:1
Aug 23, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 110 of the AP5Z1 protein (p.Arg110Gln). This variant is present in population databases (rs201481802, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with AP5Z1-related conditions. ClinVar contains an entry for this variant (Variation ID: 240942). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Hereditary spastic paraplegia Uncertain:1
Sep 01, 2019
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
14
DANN
Uncertain
0.99
DEOGEN2
Benign
0.017
T;T
Eigen
Benign
-0.66
Eigen_PC
Benign
-0.67
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.71
.;T
M_CAP
Benign
0.0092
T
MetaRNN
Benign
0.020
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.95
L;L
PhyloP100
0.59
PrimateAI
Benign
0.20
T
PROVEAN
Benign
-1.0
N;.
REVEL
Benign
0.028
Sift
Benign
0.35
T;.
Sift4G
Benign
0.24
T;.
Polyphen
0.40
B;B
Vest4
0.13
MVP
0.030
ClinPred
0.014
T
GERP RS
-0.12
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.031
gMVP
0.057
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201481802; hg19: chr7-4821348; COSMIC: COSV108196592; COSMIC: COSV108196592; API